Lee, Inki
Lim, Ilhan http://orcid.org/0000-0002-5903-1659
Byun, Byung Hyun
Kim, Byung Il
Choi, Chang Woon
Woo, Sang-Keun
Lee, Kyo Chul
Kang, Joo Hyun
Kil, Hee Seup
Park, Chansoo
Chi, Dae Yoon
Park, Jongwook
Song, Kanghyon
Lim, Sang Moo
Article History
Received: 10 April 2020
Accepted: 19 May 2020
First Online: 26 May 2020
Compliance with ethical standards
:
: Hee Seup Kil and Chansoo Park are employees of FutureChem Co., Ltd., Republic of Korea. Dae Yoon Chi is now an employee of FutureChem Co., Ltd. as Chief executive officer. The other authors declare no conflicts of interest.
: This study was approved by the by the Korean Ministry of Food and Drug Safety (MFDS), and the Institutional Review Board of KIRAMS (IRB No.: KIRAMS 2018-12-006-003). All procedures were performed following the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This clinical trial has been registered with the Clinical Research Information Service (ExternalRef removed), registration number KCT0003924.
: Informed consent was obtained from all individual participants included in the study.